$4.29
+0.590 (+15.95%)
At Close: Jun 23, 2026
Compound Semiconductor Market to surpass USD 111.6 billion by 2032, Says Global Market Insights inc.
04:30am, Wednesday, 22'nd Jan 2025
Compound Semiconductor Industry size is expected to register 10.9% CAGR between 2024 and 2032 propelled by electric vehicles and renewable energy. Compound Semiconductor Industry size is expected to r
111, Inc. Announces ADS Ratio Change
05:00am, Wednesday, 08'th Jan 2025
SHANGHAI , Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr
111, Inc. (YI) Q3 2024 Earnings Call Transcript
12:56pm, Wednesday, 27'th Nov 2024
111, Inc. (NASDAQ:YI ) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Ex
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
01:00am, Wednesday, 27'th Nov 2024
Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consec
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
05:00am, Thursday, 21'st Nov 2024
SHANGHAI , Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust
111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow
06:00am, Monday, 04'th Nov 2024
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr
111, Inc. Announces Change to Board of Directors
05:00am, Monday, 04'th Nov 2024
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr
111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024
05:10am, Tuesday, 22'nd Oct 2024
SHANGHAI , Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow
05:00am, Friday, 18'th Oct 2024
SHANGHAI , Oct. 18, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust
111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
06:02am, Thursday, 10'th Oct 2024
SHANGHAI , Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust
111, Inc. Announces Receipt of Notification from Nasdaq
05:00pm, Friday, 27'th Sep 2024
SHANGHAI , Sept. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indu
Surge in demand for synthetic fibers in the medical sector for manufacturing surgical garments, wound dressings, and medical textiles. Surge in demand for synthetic fibers in the medical sector for ma
111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation
07:30am, Friday, 13'th Sep 2024
SHANGHAI , Sept. 13, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus
111, Inc. (YI) Q2 2024 Earnings Call Transcript
04:06pm, Thursday, 29'th Aug 2024
111, Inc. (NASDAQ:YI ) Q2 2024 Earnings Conference Call August 29, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Conference Ca
111, Inc. Announces Second Quarter 2024 Unaudited Financial Results
02:00am, Thursday, 29'th Aug 2024
Maintained Operational Profitability for the Second Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY Held Positive Operating Cash Flow for Two Consecut
Sign In
Buy YI